Phillip John Jewsbury

Title: The Innovations of Phillip John Jewsbury

Introduction

Phillip John Jewsbury is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit cell cycle kinases. His work has implications for cancer treatment and other medical applications.

Latest Patents

Jewsbury holds a patent for "Imidazo[1,2-A]pyridine and pyrazolo[2,3-A]pyridine derivatives." This patent describes a compound of formula (I) wherein Ring A is imidazol[1,2a]pyrid-3-yl or pyrazolo[2,3a]pyrid-3-yl. The patent details the use of these compounds in the inhibition of cell cycle kinases CDK2, CDK4, and CDK6. Additionally, it outlines pharmaceutical compositions, methods, and processes for the preparation of these compounds.

Career Highlights

Jewsbury is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative solutions in drug development. His contributions have been instrumental in advancing therapeutic options for various diseases.

Collaborations

Jewsbury has collaborated with notable colleagues such as Andrew Peter Thomas and Gloria Anne Breault. These collaborations have fostered a productive environment for research and innovation in the pharmaceutical sector.

Conclusion

Phillip John Jewsbury's work exemplifies the impact of innovation in the pharmaceutical industry. His patent and collaborations highlight his commitment to advancing medical science and improving patient outcomes.